Une cour d'appel américaine a confirmé jeudi une décision en faveur de Bausch Health qui interdisait au fabricant concurrent Alvogen de commercialiser une version générique proposée du traitement de ...
Frédéric Aubrun does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback